Stock Price
19.57
Daily Change
-0.07 -0.36%
Monthly
-15.83%
Yearly
28.58%
Q2 Forecast
20.40

EPS Reference Time Actual Consensus Previous
2026-05-05 FY2026Q1 0.17 0.18 0.14
2026-03-03 FY2025Q4 0.18 0.2 0.20
2025-11-04 FY2025Q3 0.21 0.18 0.17
2025-08-05 FY2025Q2 0.23 0.17 0.20
2025-05-06 FY2025Q1 0.14 0.18 0.12



Peers Price Chg Day Year Date
Alliar Medicos A Frente 3.17 -0.08 -2.46% -47.17% May/15
Marisa Lojas 0.80 0.01 1.27% -44.83% May/15
Arezzo Industria e Comercio 18.96 0.11 0.58% -56.81% May/15
Americanas 5.10 -0.15 -2.86% -0.39% May/15
C&A Modas 10.91 -0.14 -1.27% -34.32% May/15
Clicks 24,896.00 216.00 0.88% -34.94% May/15
Grup SBF 10.97 0.59 5.68% -0.09% May/14
Cogna Educacao 2.54 -0.07 -2.68% -19.37% May/15
Fleury 15.59 -0.37 -2.32% 24.22% May/15
Fomento Economico Mexicano 121.27 -0.97 -0.79% 17.28% May/15

Indexes Price Day Year Date
IBOVESPA 176545 -1,821.00 -1.02% 26.84% May/15

Raia Drogasil traded at 19.53 this Friday May 15th, decreasing 0.11 or 0.56 percent since the previous trading session. Looking back, over the last four weeks, Raia Drogasil lost 16.00 percent. Over the last 12 months, its price rose by 28.32 percent. Looking ahead, we forecast Raia Drogasil to be priced at 20.40 by the end of this quarter and at 18.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.